Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension

Rudarakanchana, Nung and Flanagan, Julia A. and Chen, Hailan and Upton, Paul D. and Machado, Rajiv and Patel, D. and Trembath, Richard C. and Morrell, Nicholas W. (2002) Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Human Molecular Genetics, 11 (13). pp. 1517-25. ISSN 0964-6906

Documents
Machado_HMG2002.pdf
[img]
[Download]
Request a copy
[img] PDF
Machado_HMG2002.pdf - Whole Document
Restricted to Repository staff only

1MB

Official URL: http://dx.doi.org/10.1093/hmg/11.13.1517

Abstract

A wide range of mutations in the type II receptor for bone morphogenetic protein (BMPR-II) have been shown to underlie primary pulmonary hypertension. To determine the mechanism of altered BMPR-II function, we employed transient transfection studies in cell lines and primary cultures of pulmonary vascular smooth muscle cells using green fluorescent protein (GFP)-tagged wild-type and mutant BMPR2 constructs and confocal microscopy to localize receptors. Substitution of cysteine residues in the ligand binding or kinase domain prevented trafficking of BMPR-II to the cell surface, and reduced binding of (125)I-BMP4. In addition, transfection of cysteine-substituted BMPR-II markedly reduced basal and BMP4-stimulated transcriptional activity of a BMP/Smad responsive luciferase reporter gene (3GC2wt-Lux), compared with wild-type BMPR-II, suggesting a dominant-negative effect of these mutants on Smad signalling. In contrast, BMPR-II containing non-cysteine substitutions in the kinase domain were localized to the cell membrane, although these also suppressed the activity of 3GC2wt-Lux. Interestingly, BMPR-II mutations within the cytoplasmic tail trafficked to the cell surface, but retained the ability to activate 3GC2wt-Lux. Transfection of mutant, but not wild-type, constructs into a mouse epithelial cell line (NMuMG cells) led to activation of p38(MAPK) and increased serum-induced proliferation compared with the wild-type receptor, which was partly p38(MAPK)-dependent. We conclude that mutations in BMPR-II heterogeneously inhibit BMP/Smad-mediated signalling by diverse molecular mechanisms. However, all mutants studied demonstrate a gain of function involving upregulation of p38(MAPK)-dependent proproliferative pathways.

Item Type:Article
Keywords:BMPRII, Pulmonary arterial hypertension
Subjects:C Biological Sciences > C700 Molecular Biology, Biophysics and Biochemistry
Divisions:College of Science > School of Life Sciences
ID Code:6327
Deposited By: Rajiv Machado
Deposited On:01 Oct 2012 16:44
Last Modified:17 Jul 2014 11:06

Repository Staff Only: item control page